Illumina - 2/17

Entry	Author	Date	Location
Genomics 2.0: Ten Years After the Bubble, it’s Getting Really Interesting Again	Luke Timmerman	10/17/11	National
Sequenom Plans $19M Lab in North Carolina, Illumina Shares Plunge, PatientSafe Advances Device, & More San Diego Life Sciences News	Bruce V. Bigelow	10/13/11	San Diego
Illumina Stock Dives on Weak Quarterly Sales Report	Luke Timmerman	10/07/11	San Diego
When Will Software for the Genome Take Off? Find out Oct. 24	Luke Timmerman	10/07/11	San Francisco
Knome Moves Beyond the Mega-Rich With Genome Analysis Service	Luke Timmerman	09/29/11	Boston
New York Life Sciences 2031: OrbiMed’s Sam Isaly on Genomics, Health Reform, and Biotech’s Future	Arlene Weintraub	09/22/11	New York
Ion Torrent’s Fast and Cheap DNA Sequencer Catches On, Even as Biologists Tighten Belts	Luke Timmerman	09/15/11	National
Consortium Find New HIV Antibodies, Zogenix Gets Drug to Clinical End Point, TrovaGene Reclaims Technology, & More San Diego Life Sciences News	Bruce V. Bigelow	08/18/11	San Diego
Complete Genomics Stock Falls on Sales Decline, as Sequencing Gets Cheaper	Luke Timmerman	08/04/11	San Francisco
Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News	Bruce V. Bigelow	08/04/11	San Diego
Trius and Bayer Sign Deal, Brooks Buys Nexus Biosystems, Wildcat Discovery Gets $7.5M Financing, & More San Diego Life Sciences News	Bruce V. Bigelow	07/28/11	San Diego
Illumina Sales Climb 36%, Profits Flat	Luke Timmerman	07/26/11	San Diego
Assay Depot Creates Online Market for Pfizer, Advanced BioHealing Expands, Organovo Finds Market for Bio-Printing Technology, & More San Diego Life Sciences News	Bruce V. Bigelow	07/14/11	San Diego
Sequenom, Illumina Team Up on Down Syndrome Test	Tom Abate	07/11/11	San Diego
Orexigen Halts U.S. Work on Weight Loss Drug, Illumina Cuts Price for Sequencing Patient Genomes, Ambit Pulls IPO, & More San Diego Life Sciences News	Bruce V. Bigelow	06/09/11	San Diego
Miller Tabak Fund Manager Says Investors Are Ignoring the Upsides in Healthcare	Arlene Weintraub	05/20/11	New York
PerkinElmer Acquires Geospiza, Beefing Up Software for DNA Analysis	Luke Timmerman	05/05/11	Seattle
PacBio Goes Commercial, Tweet by Tweet from BayBio, VCs Turn Up the Heat on FDA, & More Bay Area Life Sciences News	Luke Timmerman	04/29/11	San Francisco
Polaris Prepares for Liver Cancer Trial, Goal Draws Near for Hepatitis C Drug, & More San Diego Life Sciences News	Bruce V. Bigelow	04/28/11	San Diego
Illumina Joins $41M Bet on Oxford Nanopore	Luke Timmerman	04/26/11	San Diego
Ron Shulman, Five More Patent Attorneys Jump Ship at Wilson Sonsini, Land at Latham & Watkins	Wade Roush	04/07/11	San Francisco
After Assimilating Symyx, San Diego’s Accelrys Sets Ambitious Course for Scientific Software	Bruce V. Bigelow	03/03/11	San Diego
Quanterix, Novartis Test Out Super-Sensitive Diagnostic Tool for Neuro Disorder	Luke Timmerman	02/22/11	Boston
Genomic Health, Taking a Hit on Bottom Line, Bets Next-Gen Sequencing Will Yield Next-Gen Diagnostics	Luke Timmerman	02/15/11	San Francisco
Illumina Rides Business Surge, IntegenX Acquires GenValult, Orexigen Cuts Payroll, & More San Diego Life Science News	Bruce V. Bigelow	02/10/11	San Diego
Illumina Moving to Biogen Idec Campus	Bruce V. Bigelow	02/09/11	San Diego
Diagnostics Are Warming Up in Era of Fast, Cheap Sequencing, Says MDV’s Rowan Chapman	Luke Timmerman	02/07/11	San Francisco
Plexxikon Cancer Drug Extends Lives, Med Devices Lose Swagger, Amgen Sells Fremont Facility, & More Bay Area Life Sciences News	Luke Timmerman	01/21/11	San Francisco
From Bordeaux to San Diego: Portable Genomics on the Move	Bruce V. Bigelow	01/14/11	San Diego
Illumina Launches Desktop Gene Sequencer, Avalon Raises $200M for Ninth Fund, Quidel Offering Raises Capital for New Strategy, & More San Diego Life Sciences News	Bruce V. Bigelow	01/13/11	San Diego
Page 2 of 6	« previous page · next page »

Entry

Author

Date

Location

Genomics 2.0: Ten Years After the Bubble, it’s Getting Really Interesting Again

10/17/11

Sequenom Plans $19M Lab in North Carolina, Illumina Shares Plunge, PatientSafe Advances Device, & More San Diego Life Sciences News

Bruce V. Bigelow

10/13/11

San Diego

Illumina Stock Dives on Weak Quarterly Sales Report

Luke Timmerman